Thymoma Clinical Trials

10 recruiting

Thymoma Trials at a Glance

18 actively recruiting trials for thymoma are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 8 trials, with the heaviest enrollment activity in Shanghai, Montpellier, and Lille. Lead sponsors running thymoma studies include National Cancer Institute (NCI), Fudan University, and Erasmus Medical Center.

Browse thymoma trials by phase

Treatments under study

About Thymoma Clinical Trials

Looking for clinical trials for Thymoma? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Thymoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Thymoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Phase 2

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Thymic Epithelial TumorThymic CancerRecurrent Thymoma
National Cancer Institute (NCI)53 enrolled1 locationNCT05104736
Recruiting
Not Applicable

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Thymoma
Fudan University238 enrolled1 locationNCT02633553
Recruiting
Not Applicable

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)

Thymoma Malignant Recurrent
Institut Curie314 enrolled21 locationsNCT04731610
Recruiting

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Stomach NeoplasmsMesotheliomaPancreatic Neoplasms+2 more
National Cancer Institute (NCI)1,000 enrolled1 locationNCT01950572
Recruiting
Phase 2

HEARTS Trial for Thoracic Cancers

Non-Small Cell Lung Cancer (Stage III)Esophageal Cancer Stage I-IIIEsophagogastric Cancer Stage I-III+2 more
University of Wisconsin, Madison60 enrolled1 locationNCT07132918
Recruiting
Phase 1

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

Stage III Thymoma AJCC v8Stage IIIA Thymoma AJCC v8Stage IIIB Thymoma AJCC v8+4 more
M.D. Anderson Cancer Center37 enrolled1 locationNCT03295227
Recruiting
Phase 2

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

ThymomaThymic Carcinoma
Georgetown University18 enrolled4 locationsNCT06248515
Recruiting
Phase 2

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

ThymomaThymic Carcinoma
The First Affiliated Hospital with Nanjing Medical University20 enrolled1 locationNCT06838910
Recruiting
Phase 2

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

Peritoneal MesotheliomaAnaplastic Thyroid CarcinomasCarcinoid Tumor+3 more
Hospices Civils de Lyon154 enrolled15 locationsNCT06790706
Recruiting
Phase 2

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Carbon Ion Radiotherapy, Thymoma, Thymic Carcinoma, Radiotherapy, Chemotherapy
Jian Chen48 enrolled1 locationNCT06186726
Recruiting
Phase 2

Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma

Locally Advanced Thymoma
Second Affiliated Hospital, School of Medicine, Zhejiang University178 enrolled1 locationNCT06924619
Recruiting
Phase 2

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

Thymoma
Sun Yat-sen University45 enrolled1 locationNCT06730308
Recruiting
Not Applicable

Hypofractionated Radiotherapy for Thymic Epithelial Tumors

ThymomaThymic Epithelial TumorThymoma and Thymic Carcinoma+1 more
Rongrong Zhou100 enrolled1 locationNCT06692062
Recruiting

Myasthenia Gravis Foundation of America Global MG Patient Registry

Myasthenia GravisMyasthenia Gravis, GeneralizedMyasthenia+10 more
Myasthenia Gravis Foundation of America3,800 enrolled1 locationNCT06617741
Recruiting

Predictors and Prognostic Factors of Myasthenia Gravis Outcome

Myasthenia GravisThymomaNervous System Diseases+6 more
Assiut University30 enrolled1 locationNCT05214612
Recruiting

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

ThymomaThymic CarcinomaThymic Epithelial Tumor+1 more
Erasmus Medical Center1,020 enrolled1 locationNCT06301945
Recruiting
Not Applicable

Robot-assisted vs VATS for Thymoma

Thymoma
Shanghai Pulmonary Hospital, Shanghai, China304 enrolled2 locationsNCT06029621
Recruiting
Phase 3

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Thymoma and Thymic Carcinoma
Fudan University1 enrolled1 locationNCT02633514